Singapore markets open in 4 hours 44 minutes

JNJ Jun 2025 200.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
36.300.00 (0.00%)
As of 10:55AM EDT. Market open.
Full screen
Previous close36.30
Expiry date2025-06-20
Day's range36.30 - 36.40
Contract rangeN/A
Open interestN/A
  • Yahoo Finance Video

    Small caps, biggest themes in the media landscape: Catalysts

    On today's episode of Catalysts, hosts Seana Smith and Madison Mills break down major market trends from the rise of small-cap stocks to the mergers and acquisitions activity within the media industry. The Russell 2000 (^RUT) has risen by more than 10% in the last five trading sessions, marking the longest streak of gains for the small-cap index since April 2020. MAI Capital Management chief equity strategist Chris Grisanti believes that small caps are still "underpriced" despite the Russell 2000 having "its biggest move in terms of standard deviations that we've seen in more than 30 years over the last week." He adds that small-cap stocks are cheap buying opportunities: "I don't think it's too late to initiate positions if you haven't already." Retail stocks are on the move as shares of Five Below (FIVE) sink nearly 20% after the retailer announced its CEO Joel Anderson is resigning. The retailer also lowered its second quarter guidance. Meanwhile, shares of Vans parent company VF Corporation (VFC) are jumping on reports that the apparel company will be selling its Supreme brand to European eyewear brand EssilorLuxottica (EL.PA, ESLOY) for $1.5 billion. Paramount Global's (PARA, PARAA) plans to merge with Skydance Media have left investors pondering whether more M&A deals could be in the media landscape's future. As part of this week's Media, Streaming, & Investing: What's Next special, Market Domination host Josh Lipton breaks down analysts' forecasts for mergers and acquisitions in the media industry and the potential headwinds media companies face as the 2024 presidential election nears. LightShed Partners partner and media & technology analyst Rich Greenfield believes that "no major M&A would happen this year, and I think that's what played out," believing media M&A deals such as Paramount's merger with Skydance will be finalized in 2025 due to regulatory concerns. Catch more Yahoo Finance coverage on the media and streaming landscapes as part of this week's Media, Streaming, & Investing: What's Next special. This post was written by Melanie Riehl

  • Yahoo Finance Video

    Johnson & Johnson CFO talks Q2 earnings, medtech business

    Johnson & Johnson (JNJ) reported second-quarter earnings that beat estimates on both revenue and profit. The company posted revenue of $22.45 billion, surpassing the expected $22.34 billion, while adjusted EPS came in at $2.82, above the projected $2.71. Despite this strong performance, JNJ lowered its full-year guidance, citing impacts from recent acquisitions. Johnson & Johnson CFO Joe Wolk joins Yahoo Finance health reporter Anjalee Khemlani to discuss the results. Wolk expresses satisfaction with the company's top-line growth in the second quarter, noting expansion across various business segments and products. While acknowledging that its medtech segment's sales fell slightly short of expectations, he details the company's growth plans for this sector moving forward. Wolk highlights the recent acquisition of Abiomed, describing it as "a nice complement" that strengthens JNJ's position in the cardiovascular space. "I think we're very well positioned to play in these higher growth markets," Wolk states, remaining optimistic about the medtech business' potential despite the quarter's disappointing performance. "Continuing to come up with new innovative medicines that raise the standard of care is really what is the formula for our success," Wolk tells Yahoo Finance. For more expert insight and the latest market action, click here to watch this full episode of Catalysts. This post was written by Angel Smith

  • Yahoo Finance Video

    J&J posts Q2 earnings beat, but slashes 2024 profit forecast

    Pharmaceutical giant Johnson & Johnson (JNJ) posted its second-quarter earnings Wednesday morning, beating estimates on its top and bottom lines. JNJ also slashed its full-year profit forecast. Yahoo Finance health reporter Anjalee Khemlani highlights JNJ's earnings report on The Morning Brief. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Luke Carberry Mogan.